No products in the cart.
Leflunomide Tablets (Hepai) 10mg – Low price wholesale comparison
$2.80
Leflunomide Tablets (Hepai) provide 10mg per tablet, in a 12-tablet pack. Manufactured by Meheco Moroy Pharmaceutical. Approved under NMPA H20223506. For research use only. Supports bulk and retail distribution.?Please consult staff for other specifications and uses?
Description
Leflunomide is a pyrimidine synthesis inhibitor widely studied in autoimmune and inflammatory disease research. It acts primarily by suppressing dihydroorotate dehydrogenase (DHODH), leading to reduced T-cell proliferation and cytokine activity.
The Hepai formulation delivers precise 10mg doses per tablet, packaged in a 12-tablet box. Manufactured by Meheco Moroy Pharmaceutical Co., Ltd., approved by China’s NMPA under drug license H20223506 and base code 86901122000988. Barcode: 6927374200017.
?? This product is for laboratory research only. Not intended for human or veterinary use.
Leflunomide Tablets Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Leflunomide Tablets (Hepai) |
| Generic Name | Leflunomide |
| CAS Number | 75706-12-6 |
| Molecular Formula | C??H?F?N?O? |
| Molecular Weight | 270.21?g/mol |
| Dosage Form | Tablet |
| Strength | 10mg per tablet |
| Quantity | 12 tablets per box |
| Approval Number | H20223506 (China NMPA) |
| Product Code | 86901122000988 |
| Manufacturer | Meheco Moroy Pharmaceutical Co., Ltd. |
| Barcode | 6927374200017 |
| Intended Use | Laboratory research only |
| Storage Conditions | Store below 25°C in a dry, sealed environment |
Leflunomide Tablets Mechanism & Research Applications
Leflunomide selectively inhibits DHODH, an essential enzyme for de novo pyrimidine biosynthesis in lymphocytes. By limiting DNA/RNA precursor availability, it dampens immune cell proliferation and inflammatory signaling.
Applications include:
Rheumatoid arthritis (RA) modeling
Autoimmune disorder studies
Inflammation and cytokine pathway inhibition
T-cell and macrophage suppression
Signal transduction and immunosuppressive compound screening
Leflunomide Tablets Side Effects (Observed in Research Models)
Elevated liver enzyme markers with prolonged use
Gastrointestinal disturbances: diarrhea, abdominal discomfort
Teratogenicity in animal reproduction studies
Hematologic changes under chronic exposure
Transient fatigue or weight fluctuation in high-dose groups
All experimental use should comply with local animal care and lab safety protocols.
Safety & Handling
Use Restriction: Laboratory research only
Personal Protection: Gloves, goggles, lab coat required
Storage: Keep sealed and dry, under 25°C
Disposal: Dispose in accordance with chemical waste regulations
Core Keywords
Leflunomide tablets, Hepai leflunomide, 10mg autoimmune research compound, DHODH inhibitor for lab use, inflammation inhibitor tablets, NMPA H20223506 Leflunomide, Meheco Moroy pharmaceutical tablets, research-grade immunosuppressive agent
Research Use Disclaimer
This product is not approved for clinical, diagnostic, or therapeutic use in humans or animals. For laboratory research only. Handle with proper safety equipment and follow institutional biosafety protocols.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 26 × 28 × 26 cm |
Q1: Is this product approved for medical treatment?
A1: No. It is strictly intended for research purposes, not for therapeutic or diagnostic use.
Q2: Do you support bulk orders for institutions?
A2: Yes. We support both retail and wholesale with flexible international shipping options.
Q3: Is COA (Certificate of Analysis) available?
A3: Yes. COA and SDS documents can be provided upon request.
Q4: What studies commonly use leflunomide?
A4: It is frequently used in autoimmune disease modeling, cytokine inhibition studies, and DHODH inhibitor comparisons.
Q5: How is the product packaged?
A5: Each box contains 12 tablets, blister-packed for quality preservation.
Related products
Teriparatide Injection (Zhengu) 20??g – Low price wholesale comparison
Teriparatide Injection (Zhengu) contains recombinant human PTH (1-34) at 20??g/dose in 80??L, provided in a 2.4?mL vial (5 vials per box). Manufactured by Shanghai United Cell Biotechnology Co., Ltd. Approved under NMPA S20240005. Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$2.00Iguratimod Tablets (Aidingxin) 25?mg – Low price wholesale comparison
Iguratimod Tablets (Aidingxin) deliver 25?mg of active iguratimod per film-coated tablet, with 14 tablets per box. Manufactured by Hainan Simcere Pharmaceutical Co., Ltd., approved under NMPA H20110084. Strictly for laboratory research use only.?Please consult staff for other specifications and uses? $2.00Tofacitinib Citrate Tablets (Fufeng) 5?mg – Low price wholesale comparison
Tofacitinib Citrate Tablets (Fufeng) contain 5?mg of active tofacitinib citrate per film-coated tablet. Each bottle holds 28 tablets. Manufactured by Shandong Lukang Pharmaceutical Co., Ltd., NMPA approved (H20233995). Strictly for laboratory research use.?Please consult staff for other specifications and uses? $1.00Lornoxicam Injection (Zexi) 8?mg
Lornoxicam Injection (Zexi) delivers 8?mg of the non?steroidal anti?inflammatory agent per vial. Supplied as 10 vials per box. Manufactured by Suzhou Tianma/Tianji Biopharma Co., Ltd., approved under NMPA H20113080. For laboratory research use only.?Please consult staff for other specifications and uses?
$1.30
Reviews
There are no reviews yet.